Tobaruela-Resola, A. (. L., Milagro-Yoldi, F. (. I., Benito-Boíllos, A. (., Zulet, M. (. Á., Elorz-Carlón, M. (., Herrero-Santos, J. (. I., . . . Abete, I. (. (2024). Circulating miR‑122‑5p, miR‑151a‑3p, miR‑126‑5p and miR‑21‑5p as potential predictive biomarkers for Metabolic Dysfunction‑Associated Steatotic Liver Disease assessment.
Citación estilo ChicagoTobaruela-Resola, A.L. (Ana Luz)|||/items/7ecdb0c5-e6a9-4080-ac79-40854353aef4, et al. Circulating MiR‑122‑5p, MiR‑151a‑3p, MiR‑126‑5p and MiR‑21‑5p As Potential Predictive Biomarkers for Metabolic Dysfunction‑Associated Steatotic Liver Disease Assessment. 2024.
Cita MLATobaruela-Resola, A.L. (Ana Luz)|||/items/7ecdb0c5-e6a9-4080-ac79-40854353aef4, et al. Circulating MiR‑122‑5p, MiR‑151a‑3p, MiR‑126‑5p and MiR‑21‑5p As Potential Predictive Biomarkers for Metabolic Dysfunction‑Associated Steatotic Liver Disease Assessment. 2024.